Pharmacogenomics could help avert adverse drug reactions in about 2 million Americans per year that cause about 100,000 deaths. Forty percent (40%) of consumers polled think that doctors can reduce the risk of drug side effects in patients through genetic testing, however almost double, 79%, would consider genetic testing, known as pharmacogenomics, to lower their own risk … [Read more...] about Wamberg Genomic Survey: 79% of Consumers Would Consider Genetic Testing to Limit Risk of Drug Side Effects